elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-720CEBE3-7BDE-43AF-A608-9F959484F544
Q27852097-720CEBE3-7BDE-43AF-A608-9F959484F544
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-720CEBE3-7BDE-43AF-A608-9F959484F544
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P921
Q27852097-720CEBE3-7BDE-43AF-A608-9F959484F544
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-720CEBE3-7BDE-43AF-A608-9F959484F544
rank
NormalRank
type
BestRank
Statement
P921
multicenter trial